{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:57:57Z","timestamp":1786121877998,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03363-8","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T07:08:00Z","timestamp":1786086480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6923-1470","authenticated-orcid":false,"given":"Ufuk","family":"Demirci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Baysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metban","family":"Mastanzade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis Sabriye","family":"Bozer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"G\u00fclt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faz\u0131l \u00c7a\u011fr\u0131","family":"Hunutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00fcbra","family":"Oral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayfer","family":"Ged\u00fck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhan","family":"Diz-K\u00fc\u00e7\u00fckkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Canbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"\u00d6zmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130brahim","family":"Beyhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Yi\u011fitba\u015f\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafiye","family":"\u00c7ift\u00e7iler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130lknur","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Turun\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevil","family":"Sadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcreyya","family":"Yi\u011fit Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samet","family":"Yaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe Hilal","family":"Ero\u011flu K\u00fc\u00e7\u00fckdiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fato\u015f Dilan","family":"K\u00f6seo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"G\u00fcven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Can","family":"U\u011fur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serhat","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysun","family":"\u015eent\u00fcrk Y\u0131k\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tar\u0131k Onur","family":"Tiryaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha Ulutan","family":"Kars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melda","family":"C\u00f6mert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekeriya","family":"Aks\u00f6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abd\u00fclkerim","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130pek","family":"Y\u00f6nal Hindilerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fehmi","family":"Hindilerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcray","family":"Saydam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vildan","family":"\u00d6zkocaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga Meltem","family":"Akay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Muzaffer","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"G\u00fcrkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leylag\u00fcl","family":"Kaynar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seval","family":"Akp\u0131nar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahir","family":"\u00d6zkalemka\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif G.","family":"\u00dcmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Emre","family":"E\u015fkazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"issue":"16","key":"3363_CR1","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1182\/blood.2024025627","volume":"145","author":"A Guy","year":"2025","unstructured":"Guy A, Morange PE, James C (2025) How I approach the treatment of thrombotic complications in patients with myeloproliferative neoplasms. Blood 145(16):1769\u20131779. https:\/\/doi.org\/10.1182\/blood.2024025627","journal-title":"Blood"},{"key":"3363_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11899-018-0446-x","volume":"13","author":"IJ Akpan","year":"2018","unstructured":"Akpan IJ, Stein BL (2018) Splanchnic vein thrombosis in the myeloproliferative neoplasms. Curr Hematol Malig Rep 13:183\u2013190. https:\/\/doi.org\/10.1007\/s11899-018-0446-x","journal-title":"Curr Hematol Malig Rep"},{"key":"3363_CR3","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1016\/j.ejim.2018.03.009","volume":"52","author":"D Cattaneo","year":"2018","unstructured":"Cattaneo D, Gianelli U, Bianchi P, Cortelezzi A, Iurlo A (2018) Heterogeneity among splanchnic vein thrombosis associated with myeloproliferative neoplasms. Eur J Intern Med 52:e25\u2013e26. https:\/\/doi.org\/10.1016\/j.ejim.2018.03.009","journal-title":"Eur J Intern Med"},{"issue":"25","key":"3363_CR4","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1182\/blood-2011-09-376517","volume":"120","author":"JH Smalberg","year":"2012","unstructured":"Smalberg JH, Arends LR, Valla DC, Kiladjian JJ, Janssen HL, Leebeek FW (2012) Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood 120(25):4921\u20134928. https:\/\/doi.org\/10.1182\/blood-2011-09-376517","journal-title":"Blood"},{"key":"3363_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/10760296221097969","volume":"28","author":"L Papageorgiou","year":"2022","unstructured":"Papageorgiou L, Elalamy I, Vandreden P, Gerotziafas GT (2022) Thrombotic and hemorrhagic issues associated with myeloproliferative neoplasms. Clin Appl Thromb Hemost 28:10760296221097969. https:\/\/doi.org\/10.1177\/10760296221097969","journal-title":"Clin Appl Thromb Hemost"},{"issue":"24","key":"3363_CR6","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1200\/JCO.2012.42.1925","volume":"30","author":"M Hultcrantz","year":"1973","unstructured":"Hultcrantz M, Kristinsson SY, Andersson TM et al (1973) Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study. J Clin Oncol 30(24):2995\u20133001. https:\/\/doi.org\/10.1200\/JCO.2012.42.1925","journal-title":"J Clin Oncol"},{"key":"3363_CR7","doi-asserted-by":"publisher","first-page":"10008","DOI":"10.1055\/s-0034-1370794","volume":"5","author":"S Kelliher","year":"2021","unstructured":"Kelliher S, Falanga A (2021) Thrombosis in myeloproliferative neoplasms: A clinical and pathophysiological perspective. Thrombosis Update 5:10008. https:\/\/doi.org\/10.1055\/s-0034-1370794","journal-title":"Thrombosis Update"},{"key":"3363_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2025.109319","volume":"250","author":"S Cardi","year":"2025","unstructured":"Cardi S, Wolf S, Fumaggali RM et al (2025) Splanchnic vein thrombosis (2003\u20132022): a Swiss nationwide epidemiological study. Thromb Res 250:109319. https:\/\/doi.org\/10.1016\/j.thromres.2025.109319","journal-title":"Thromb Res"},{"issue":"9","key":"3363_CR9","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1007\/s00277-025-06606-5","volume":"104","author":"E Morsia","year":"2025","unstructured":"Morsia E, Ranalli P, Baldoni S et al (2025) Genetic insights into myeloproliferative neoplasms and unusual sites thrombosis. Ann Hematol 104(9):4525\u20134529. https:\/\/doi.org\/10.1007\/s00277-025-06606-5","journal-title":"Ann Hematol"},{"issue":"5","key":"3363_CR10","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/ajh.26896","volume":"98","author":"JJ Kiladjian","year":"2023","unstructured":"Kiladjian JJ, Cassinat B (2023) Myeloproliferative neoplasms and splanchnic vein thrombosis: contemporary diagnostic and therapeutic strategies. Am J Hematol 98(5):794\u2013800. https:\/\/doi.org\/10.1002\/ajh.26896","journal-title":"Am J Hematol"},{"key":"3363_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.thromres.2022.08.003","volume":"218","author":"D Tremblay","year":"2022","unstructured":"Tremblay D, Winters A, Beckman JD et al (2022) Splanchnic vein thrombosis associated with myeloproliferative neoplasms. Thromb Res 218:8\u201316. https:\/\/doi.org\/10.1016\/j.thromres.2022.08.003","journal-title":"Thromb Res"},{"issue":"11","key":"3363_CR12","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1038\/bcj.2016.103","volume":"6","author":"V De Stefano","year":"2016","unstructured":"De Stefano V, Vannucchi AM, Ruggeri M et al (2016) Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients. Blood Cancer J 6(11):e493. https:\/\/doi.org\/10.1038\/bcj.2016.103","journal-title":"Blood Cancer J"},{"issue":"15","key":"3363_CR13","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1182\/bloodadvances.2020002414","volume":"4","author":"PE Debureaux","year":"2020","unstructured":"Debureaux PE, Cassinat B, Soret-Dulphy J et al (2020) Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses. Blood Adv 4(15):3708\u20133715. https:\/\/doi.org\/10.1182\/bloodadvances.2020002414","journal-title":"Blood Adv"},{"issue":"Supplement 1","key":"3363_CR14","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1182\/blood-2025-1026","volume":"146","author":"D Tremblay","year":"2025","unstructured":"Tremblay D, Ko A, Chrysafi P et al (2025) Cytoreductive therapy reduces recurrent thrombosis in patients with myeloproliferative neoplasm-associated splanchnic vein thrombosis: A global abdominal\/splanchnic thrombosis retrospective observational study (GASTRO-MPN) study of 757 patients. Blood 146(Supplement 1):1026. https:\/\/doi.org\/10.1182\/blood-2025-1026","journal-title":"Blood"},{"issue":"1","key":"3363_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/bjh.20141","volume":"207","author":"N Batyrbekova","year":"2025","unstructured":"Batyrbekova N, Hultcrantz M, Ravn Landtblom A et al (2025) Impact of age and time since diagnosis on thrombosis risk in myeloproliferative neoplasm patients: a nationwide register-based matched cohort study. Br J Haematol 207(1):189\u2013200. https:\/\/doi.org\/10.1111\/bjh.20141","journal-title":"Br J Haematol"},{"issue":"5","key":"3363_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7326\/M17-0028","volume":"168","author":"M Hultcrantz","year":"2018","unstructured":"Hultcrantz M, Bj\u00f6rkholm M, Dickman PW et al (2018) Risk for arterial and venous thrombosis in patients with myeloproliferative neoplasms: a population-based cohort study. Ann Intern Med 168(5):317\u2013325. https:\/\/doi.org\/10.7326\/M17-0028","journal-title":"Ann Intern Med"},{"issue":"1","key":"3363_CR17","first-page":"27","volume":"10","author":"M Tevet","year":"2015","unstructured":"Tevet M, Ionescu R, Dragan C, Lupu AR (2015) Influence of the JAK2 V617F Mutation and Inherited Thrombophilia on the Thrombotic Risk among Patients with Myeloproliferative Disorders. Maedica (Bucur) 10(1):27\u201332","journal-title":"Maedica (Bucur)"},{"issue":"3","key":"3363_CR18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11239-012-0738-2","volume":"34","author":"I Yonal","year":"2012","unstructured":"Yonal I, Pinarbas\u0131 B, Hindilerden F et al (2012) The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis. J Thromb Thrombolysis 34(3):388\u2013396. https:\/\/doi.org\/10.1007\/s11239-012-0738-2","journal-title":"J Thromb Thrombolysis"},{"issue":"9","key":"3363_CR19","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1055\/s-0038-1667015","volume":"118","author":"A Guadall","year":"2018","unstructured":"Guadall A, Lesteven E, Letort G et al (2018) Endothelial cells harbouring the JAK2V617F mutation display pro-adherent and pro-thrombotic features. Thromb Haemost 118(9):1586\u20131599. https:\/\/doi.org\/10.1055\/s-0038-1667015","journal-title":"Thromb Haemost"},{"issue":"10","key":"3363_CR20","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1055\/a-2498-4849","volume":"125","author":"B De Moner","year":"2025","unstructured":"De Moner B, Martinez-Sanchez J, Garrote M et al (2025) Endothelial damage in JAK2V617F myeloproliferative neoplasms with splanchnic vein thrombosis. Thromb Haemost 125(10):1010\u20131022. https:\/\/doi.org\/10.1055\/a-2498-4849","journal-title":"Thromb Haemost"},{"issue":"3","key":"3363_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4274\/tjh.galenos.2024.2024.0161","volume":"41","author":"R Diz-K\u00fc\u00e7\u00fckkaya","year":"2024","unstructured":"Diz-K\u00fc\u00e7\u00fckkaya R, \u0130yig\u00fcn T, Albayrak \u00d6, Eker C, G\u00fcnel T (2024) JAK2V617F Mutation in Endothelial Cells of Patients with Atherosclerotic Carotid Disease. Turk J Haematol 41(3):167\u2013174. https:\/\/doi.org\/10.4274\/tjh.galenos.2024.2024.0161","journal-title":"Turk J Haematol"},{"issue":"1","key":"3363_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4274\/tjh.galenos.2024.2023.0430","volume":"41","author":"Z Narl\u0131 \u00d6zdemir","year":"2024","unstructured":"Narl\u0131 \u00d6zdemir Z, \u0130pek Y, Pat\u0131r P et al (2024) Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients. Turk J Haematol 41(1):26\u201336. https:\/\/doi.org\/10.4274\/tjh.galenos.2024.2023.0430","journal-title":"Turk J Haematol"},{"key":"3363_CR23","doi-asserted-by":"publisher","unstructured":"How C, Chrysafi P, Ko A, et al. Anticoagulation Management of Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: A Global Abdominal\/Splanchnic Thrombosis Retrospective Observational Study in 486 MPN Patients (GASTRO-MPN). Blood. Volume 144, Supplement 1,2024, Page 16, https:\/\/doi.org\/10.1016\/j.jtha.2024.06.029","DOI":"10.1016\/j.jtha.2024.06.029"},{"key":"3363_CR24","doi-asserted-by":"publisher","first-page":"S349","DOI":"10.1111\/ejh.13335","volume":"19","author":"D Tremblay","year":"2019","unstructured":"Tremblay D, Vogel A, Hoffman R et al (2019) Outcomes of Splanchnic Vein Thrombosis in Patients with Myeloproliferative Neoplasms Treated with Direct Oral Anticoagulants. Clin Lymphoma Myeloma Leuk 19:S349\u2013S350. https:\/\/doi.org\/10.1111\/ejh.13335","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"3363_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s11239-024-03043-5","volume":"58","author":"M Baysal","year":"2025","unstructured":"Baysal M, Aksoy E, Bedir KH et al (2025) Real-world data on direct oral anticoagulants in BCR::ABL1-negative myeloproliferative neoplasms (MPNs): a multicenter retrospective study on behalf of scientific subcommittee on MPNs for Turkish society of hematology. J Thromb Thrombolysis 58(2):284\u2013298. https:\/\/doi.org\/10.1007\/s11239-024-03043-5","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"3363_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/17474086.2023.2174515","volume":"16","author":"M Baysal","year":"2023","unstructured":"Baysal M, Bayrak M, E\u015fkazan AE (2023) Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review. Expert Rev Hematol 16(2):131\u2013140. https:\/\/doi.org\/10.1080\/17474086.2023.2174515","journal-title":"Expert Rev Hematol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03363-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03363-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03363-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T07:08:01Z","timestamp":1786086481000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03363-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":26,"alternative-id":["3363"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03363-8","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}